Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million ...

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research, led by the ...

A majority of Americans are not planning to get a COVID-19 booster vaccine this season, according to a survey. The Pew Research Center's survey of 9,593 U.S. adults, conducted between October 21 and ...

By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...

The Food and Drug Administration authorized an updated formula for mRNA COVID-19 vaccines to adjust for the XBB1.5 variant this fall amid a surge in cases right after summer. With a long schedule of ...

Pfizer's COVID-19 booster shot yields mild to moderate side effects, much like its second dose. Injection-site pain is the most common, as well as headaches and fatigue. See more stories on Insider's ...

Today, the US Food and Drug Administration authorized new mRNA booster shots from Moderna and Pfizer, and a panel of outside experts that advises the Centers for Disease Control and Prevention voted ...